CD59 has several additional functions relevant to immune function, including the complement activation cascade where it binds to C8 and C9 to inhibit the formation of membrane attack complex (MAC) pores, conferring cancer cells resistant to complement-mediated cell lysis (54, 55). This evidence concerns the gene C9 and cancer.